Skip to main content
Clinical Trials/ISRCTN36009809
ISRCTN36009809
Completed
未知

Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose and blood pressure lowering drugs

niversity of East Anglia0 sites23 target enrollmentFebruary 5, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes mellitus
Sponsor
niversity of East Anglia
Enrollment
23
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36056388/ (added 05/09/2022)

Registry
who.int
Start Date
February 5, 2020
End Date
April 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of East Anglia

Eligibility Criteria

Inclusion Criteria

  • 1\. People with T2DM prescribed oral blood glucose lowering medication that are non\-adherent to oral blood glucose and/or blood pressure lowering drugs
  • 2\. Aged 35\-75 years
  • 3\. Smartphone user and willing to use platform facilities (digital health resources) or have access to an electronic device (e.g. computer)
  • 4\. All ethnicities
  • 5\. Able to understand text messages in English

Exclusion Criteria

  • 1\. People with T2DM that use parenteral medication (e.g. insulin) for diabetes
  • 2\. People in which, according to screening data collected, adherence data is not valid due to hospital admission or in which medication is dispensed by different pharmacies
  • 3\. People who use medication\-intake supporting services provided by the pharmacy (i.e. repeat dispensing and pill packaging)
  • 4\. People who indicate in the questionnaire that they suffer from the following major mental health disorders: depression, schizophrenia, psychosis or suicidality
  • 5\. Any significant medical reason for exclusion as determined by the researchers
  • 6\. Unable or not willing to provide written informed consent
  • 7\. Not willing to accept information transfer concerning participation in the study, and/or information regarding a participants’ health (like laboratory results or physical examination) and/or eventual adverse events to and from his GP and/or pharmacist
  • 8\. People who are involved in current research or have recently been involved in any research prior to recruitment

Outcomes

Primary Outcomes

Not specified

Similar Trials